Influence of pharmaceuticals on the development of obesity

Bazhora, Ya. I.; Lahoda, D. O.; Velychko, V. I.

dc.contributor.author	Bazhora, Ya. I.	en
dc.contributor.author	Lahoda, D. O.	en
dc.contributor.author	Velychko, V. I.	en
dc.date.accessioned	2023-02-21T08:32:55Z
dc.date.available	2023-02-21T08:32:55Z
dc.date.issued	2023
dc.identifier.citation	Bazhora Ya. I., Lahoda D. O., Velychko V. I. Influence of pharmaceuticals on the development of obesity // European Journal of Molecular and Clinical Medicine. 2023. Vol. 10, n. 01. P. 4122–4126.	en
dc.identifier.uri	https://repo.odmu.edu.ua:443/xmlui/handle/123456789/12134
dc.description.abstract	Ukraine has been at war for almost a year. This cannot but affect the mental health of the nation. Anxiety-depressive disorders (ADD) and other manifestations of psychological health disorders are increasingly registered among our citizens. At the same time, it is well known that certain groups of antipsychotic and antidepressant drugs have an impact on body weight (BW). Material and methods: By design, the study involved 154 patients aged 18 to 55 years who were not diagnosed with obesity prior to the war. The study was conducted at the Department of Family Medicine and Polyclinic Therapy of the Odesa National Medical University. By design, patients were divided into three groups: 1 group - patients who received antipsychotics for the treatment of ADD; 2 group - patients who received antidepressants and group 3 - patients who did not receive pharmacological treatment of ADD.	en
dc.language.iso	en	en
dc.subject	pharmaceuticals	en
dc.subject	obesity	en
dc.subject	mental health of the nation	en
dc.subject	anxiety-depressive disorders	en
dc.title	Influence of pharmaceuticals on the development of obesity	en
dc.type	Article	en